Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer-Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aerosolized Amphotericin B Lipid Complex as Adjunctive Treatment for Fungal Lung Infection in Patients with Cancer-Related Immunosuppression and Recipients of Hematopoietic Stem Cell Transplantation
Authors
Keywords
-
Journal
PHARMACOTHERAPY
Volume 33, Issue 10, Pages 1035-1043
Publisher
Wiley
Online
2013-06-19
DOI
10.1002/phar.1309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy for Invasive Mold Disease in Severely Immunosuppressed Patients
- (2013) A. Safdar CLINICAL INFECTIOUS DISEASES
- Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation
- (2010) Víctor Monforte et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Intrapulmonary Disposition of Amphotericin B After Aerosolized Delivery of Amphotericin B Lipid Complex (Abelcet; ABLC) in Lung Transplant Recipients
- (2010) Shahid Husain et al. TRANSPLANTATION
- Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention
- (2009) A Safdar et al. BONE MARROW TRANSPLANTATION
- Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
- (2009) G.N. Pongas et al. CLINICAL MICROBIOLOGY AND INFECTION
- Inhaled therapeutics for prevention and treatment of pneumonia
- (2009) Amar Safdar et al. Expert Opinion On Drug Safety
- Randomized phase III study of granulocyte transfusions in neutropenic patients
- (2008) M G Seidel et al. BONE MARROW TRANSPLANTATION
- Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
- (2008) Yasmine Nivoix et al. CLINICAL INFECTIOUS DISEASES
- Aerosolized Liposomal Amphotericin B for the Prevention of Invasive Pulmonary Aspergillosis during Prolonged Neutropenia: A Randomized, Placebo‐Controlled Trial
- (2008) Bart J. Rijnders et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
- (2008) D. Neofytos et al. CLINICAL INFECTIOUS DISEASES
- How Best to Deliver Aerosol Medications to Mechanically Ventilated Patients
- (2008) Rajiv Dhand et al. CLINICS IN CHEST MEDICINE
- Current Therapies and Technological Advances in Aqueous Aerosol Drug Delivery
- (2008) Alan B. Watts et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: Data from a randomized placebo-controlled trial
- (2008) Lennert Slobbe et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Efficiency and Safety of Inhaled Amphotericin B Lipid Complex (Abelcet) in the Prophylaxis of Invasive Fungal Infections Following Lung Transplantation
- (2008) J.M. Borro et al. TRANSPLANTATION PROCEEDINGS
- Pulmonary Drug Delivery System for inhalation therapy in mechanically ventilated patients
- (2007) Rajiv Dhand et al. Expert Review of Medical Devices
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started